JP6419074B2 - ショックの治療に使用するためのアドレナリンと抗うつ剤との組み合わせ - Google Patents
ショックの治療に使用するためのアドレナリンと抗うつ剤との組み合わせ Download PDFInfo
- Publication number
- JP6419074B2 JP6419074B2 JP2015535014A JP2015535014A JP6419074B2 JP 6419074 B2 JP6419074 B2 JP 6419074B2 JP 2015535014 A JP2015535014 A JP 2015535014A JP 2015535014 A JP2015535014 A JP 2015535014A JP 6419074 B2 JP6419074 B2 JP 6419074B2
- Authority
- JP
- Japan
- Prior art keywords
- adrenaline
- shock
- antidepressant
- pharmaceutical composition
- liquid preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306207.7 | 2012-10-03 | ||
| EP12306207 | 2012-10-03 | ||
| PCT/EP2013/070598 WO2014053579A1 (en) | 2012-10-03 | 2013-10-02 | A combination of adrenalin with an antidepressant for use in the treatment of shocks |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015536907A JP2015536907A (ja) | 2015-12-24 |
| JP6419074B2 true JP6419074B2 (ja) | 2018-11-07 |
Family
ID=47073380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015535014A Active JP6419074B2 (ja) | 2012-10-03 | 2013-10-02 | ショックの治療に使用するためのアドレナリンと抗うつ剤との組み合わせ |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20150306065A1 (enExample) |
| EP (1) | EP2903607B1 (enExample) |
| JP (1) | JP6419074B2 (enExample) |
| KR (1) | KR102145786B1 (enExample) |
| CN (1) | CN104780916B (enExample) |
| AU (1) | AU2013326470B2 (enExample) |
| BR (1) | BR112015007524B1 (enExample) |
| CA (1) | CA2887330C (enExample) |
| CY (1) | CY1119514T1 (enExample) |
| DK (1) | DK2903607T3 (enExample) |
| EA (1) | EA030763B1 (enExample) |
| ES (1) | ES2647597T3 (enExample) |
| HR (1) | HRP20171442T1 (enExample) |
| HU (1) | HUE034638T2 (enExample) |
| IL (1) | IL238120B (enExample) |
| IN (1) | IN2015DN02849A (enExample) |
| LT (1) | LT2903607T (enExample) |
| MA (1) | MA37970B2 (enExample) |
| MX (1) | MX359198B (enExample) |
| NO (1) | NO2903607T3 (enExample) |
| NZ (1) | NZ707124A (enExample) |
| PH (1) | PH12015500755B1 (enExample) |
| PL (1) | PL2903607T3 (enExample) |
| PT (1) | PT2903607T (enExample) |
| RS (1) | RS56392B1 (enExample) |
| SG (1) | SG11201502645VA (enExample) |
| SI (1) | SI2903607T1 (enExample) |
| SM (1) | SMT201700502T1 (enExample) |
| TN (1) | TN2015000126A1 (enExample) |
| WO (1) | WO2014053579A1 (enExample) |
| ZA (1) | ZA201502441B (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705942A (en) * | 1969-09-29 | 1972-12-12 | Ciba Geigy Corp | Treatment of glaucoma employing imipramine or desmethylimipramine |
| TW200744568A (en) * | 2006-02-28 | 2007-12-16 | Verus Pharmaceuticals Inc | Epinephrine dosing regimens |
| US20070293582A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| EP2818184B1 (en) * | 2007-11-16 | 2018-10-31 | Allergan, Inc. | Compositions and methods for treating Purpura |
| SE533552C2 (sv) * | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| US20100190860A1 (en) * | 2009-01-09 | 2010-07-29 | The Brigham And Women's Hospital, Inc. | Methods for selectively enhancing antinociceptive potency of local anesthetics |
| CN101987198B (zh) * | 2009-08-06 | 2014-08-13 | 北京美倍他药物研究有限公司 | 药物组合物 |
-
2013
- 2013-10-02 EP EP13771500.9A patent/EP2903607B1/en active Active
- 2013-10-02 WO PCT/EP2013/070598 patent/WO2014053579A1/en not_active Ceased
- 2013-10-02 AU AU2013326470A patent/AU2013326470B2/en active Active
- 2013-10-02 ES ES13771500.9T patent/ES2647597T3/es active Active
- 2013-10-02 PT PT137715009T patent/PT2903607T/pt unknown
- 2013-10-02 SG SG11201502645VA patent/SG11201502645VA/en unknown
- 2013-10-02 KR KR1020157010740A patent/KR102145786B1/ko active Active
- 2013-10-02 NO NO13771500A patent/NO2903607T3/no unknown
- 2013-10-02 SM SM20170502T patent/SMT201700502T1/it unknown
- 2013-10-02 PL PL13771500T patent/PL2903607T3/pl unknown
- 2013-10-02 EA EA201500374A patent/EA030763B1/ru not_active IP Right Cessation
- 2013-10-02 CN CN201380057617.0A patent/CN104780916B/zh active Active
- 2013-10-02 NZ NZ707124A patent/NZ707124A/en unknown
- 2013-10-02 HR HRP20171442TT patent/HRP20171442T1/hr unknown
- 2013-10-02 HU HUE13771500A patent/HUE034638T2/en unknown
- 2013-10-02 JP JP2015535014A patent/JP6419074B2/ja active Active
- 2013-10-02 RS RS20170973A patent/RS56392B1/sr unknown
- 2013-10-02 CA CA2887330A patent/CA2887330C/en active Active
- 2013-10-02 IN IN2849DEN2015 patent/IN2015DN02849A/en unknown
- 2013-10-02 DK DK13771500.9T patent/DK2903607T3/en active
- 2013-10-02 SI SI201330817T patent/SI2903607T1/sl unknown
- 2013-10-02 MA MA37970A patent/MA37970B2/fr unknown
- 2013-10-02 MX MX2015004323A patent/MX359198B/es active IP Right Grant
- 2013-10-02 LT LTEP13771500.9T patent/LT2903607T/lt unknown
- 2013-10-02 US US14/433,549 patent/US20150306065A1/en not_active Abandoned
- 2013-10-02 BR BR112015007524-0A patent/BR112015007524B1/pt active IP Right Grant
-
2015
- 2015-04-02 IL IL238120A patent/IL238120B/en active IP Right Grant
- 2015-04-02 TN TNP2015000126A patent/TN2015000126A1/fr unknown
- 2015-04-06 PH PH12015500755A patent/PH12015500755B1/en unknown
- 2015-04-10 ZA ZA2015/02441A patent/ZA201502441B/en unknown
-
2017
- 2017-10-31 CY CY20171101135T patent/CY1119514T1/el unknown
-
2018
- 2018-12-18 US US16/223,750 patent/US10952987B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10881647B2 (en) | Neosaxitoxin combination formulations for prolonged local anesthesia | |
| Montorsi et al. | Pharmacological management of erectile dysfunction | |
| CN102196819A (zh) | 局部麻醉用组合物 | |
| JP6419074B2 (ja) | ショックの治療に使用するためのアドレナリンと抗うつ剤との組み合わせ | |
| JP2620642B2 (ja) | 麻薬性鎮痛剤とベンゾジアゼピンとを組み合わせて非経口投与した後に観察される平均血圧の低下を拮抗させるための医薬品 | |
| JPH09511519A (ja) | β−受容体ブロッカーおよび局所麻酔剤の新規な組合せ | |
| Broderick | Intracavernous pharmacotherapy: treatment for the aging erectile response | |
| US12171807B2 (en) | Use of bremelanotide in patients with controlled hypertension | |
| Kiss et al. | Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats. | |
| CN110402142A (zh) | 含局麻药的酸性乳液组合物 | |
| CA2643529C (en) | Method and composition for enhancement of male erectile function | |
| HK1211846B (zh) | 用於治疗休克的肾上腺素与抗抑郁剂的组合 | |
| Varner et al. | Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity | |
| Rabbani et al. | Prostaglandin E1 for the medical management of erectile dysfunction | |
| Dettori et al. | Hydroxyethyl starches and pruritus: a real problem? | |
| KR20060136415A (ko) | 고혈압증 치료약 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160902 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170425 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170508 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170807 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171108 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20171108 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180312 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180518 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180809 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180910 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181009 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6419074 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |